Legacy Financial Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
1,916
+36
+2% +$7.48K 0.06% 256
2026
Q1
$397K Buy
1,880
+24
+1% +$5.17K 0.06% 271
2025
Q4
$381K Sell
1,856
-46
-2% -$8.66K 0.05% 272
2025
Q3
$298K Buy
1,902
+1
+0.1% +$154 0.04% 319
2025
Q2
$319K Buy
1,901
+23
+1% +$3.41K 0.05% 263
2025
Q1
$259K Sell
1,878
-3
-0.2% -$382 0.04% 298
2024
Q4
$222K Buy
+1,881
New +$220K 0.04% 318
2019
Q2
Sell
-630
Closed -$30K 235
2019
Q1
$30K Buy
630
+20
+3% +$1K 0.01% 373
2018
Q4
$27K Hold
610
0.01% 352
2018
Q3
$32K Hold
610
0.01% 301
2018
Q2
$31K Hold
610
0.01% 310
2018
Q1
$39K Hold
610
0.02% 274
2017
Q4
$37K Buy
+610
New +$37.7K 0.02% 283

Other funds holding CAH

Legacy Financial Advisors's CAH Position: Q2 2026 in Review

Legacy Financial Advisors increased its Cardinal Health (CAH) stake by 1.9% in Q2 2026, buying an estimated $7.48K and bringing the position to 1,916 shares worth $455K. The position accounts for 0.06% of the portfolio, ranked #256.

Legacy Financial Advisors first reported a position in CAH in Q4 2017 and has held it in 13 quarters since. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Legacy Financial Advisors held 1,916 shares of Cardinal Health worth $455K as of Q2 2026.
  • Legacy Financial Advisors bought 36 Cardinal Health shares in Q2 2026, an estimated $7.48K.
  • Cardinal Health made up 0.06% of Legacy Financial Advisors's portfolio in Q2 2026, its #256 holding.
  • Legacy Financial Advisors first reported a position in Cardinal Health in Q4 2017 and has held it in 13 quarters since.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Legacy Financial Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.